
Uterine fibroids are benign smooth muscle tumours affecting up to 80% of women by age 50, causing heavy menstrual bleeding, pelvic pressure, and infertility. GnRH antagonists, relugolix and elagolix, and combination hormonal therapies provide effective medical management of associated bleeding. Minimally invasive surgical options and focused ultrasound ablation have expanded non-medical treatment choices.